Premium
Review suggests anti‐cytokine treatment can improve treatment‐resistant depression
Publication year - 2017
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30204
Subject(s) - depression (economics) , psychopharmacology , cytokine , medicine , randomized controlled trial , depressive symptoms , citation , treatment resistant depression , psychotherapist , psychiatry , psychology , clinical psychology , major depressive disorder , anxiety , library science , computer science , economics , macroeconomics , cognition
A review and meta‐analysis of 20 studies, including seven randomized controlled trials, has concluded that anti‐cytokine therapy significantly improves depressive symptoms and could be particularly effective for individuals with treatment‐resistant depression and increased inflammation. Results of the review were published online Oct. 18, 2016 in Molecular Psychiatry .